— ONCOLOGY CLINICAL RESEARCH
World Research Link actively conducts community-embedded oncology protocols across our network. Review currently enrolling studies, sponsor information, and protocol details below.
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
Treatment naive advanced/metastatic urothelial carcinoma with FGFR3 alteration
PIK3CA-mutated HR+/HER2- advanced breast cancer
Chemotherapy-induced nausea and vomiting
Protocol J4G-MC-JZVD / FORAGER-2
Trial Phase: 3
Protocol J6M-MC-JSGD / PIKALO-2
Trial Phase: 3
Protocol J2R-MC-YAAD
Trial Phase: 2
GENELUX CORPORATION
TAKEDA
Advanced NSCLC after progression on frontline immunotherapy-based maintenance
Anemia in ESA-naive lower-risk MDS requiring RBC transfusions
Protocol Olvi-Vec-NSCLC-025
Trial Phase: 2
Protocol TAK-226-3001 / ELRISE MDS
Trial Phase: 3
Begin the onboarding process
We respond to all sponsor, physician, and patient inquiries within one business day. Our structured onboarding process ensures rapid site activation and rigorous compliance from day one.
Community-embedded research sites
Our trial network spans multiple community clinics, bringing advanced clinical trials directly to local patient populations. We integrate research seamlessly into trusted, everyday healthcare environments.
Central Coordination
Our centralized headquarters manages regulatory compliance, staff training, and trial logistics, keeping the burden off local physicians.
Site Feasibility
We rapidly assess local clinic patient panels to match complex sponsor protocols with highly qualified, community-embedded medical practices.